IBPS Participates at Biosimilars & Biologics 2018
Over 200+ proteins, peptides and biosimilars delegates representing leading biotech companies, global pharmaceutical organisations and internationally renowned academic institutions at the Biosimilars & Biologics 2018
Pragmatic Implementation of Clinical Trials
An Indian generic pharmaceutical giant was keen on developing in-house biosimilars to expand its portfolio in the domestic as well as global markets.
Is India the next hub for Technical Writing for Drug Development?
how technical writing opportunities have proliferated in the drug development market in India..
IBPS Participated at 3rd Annual Biosimilars APAC Summit
Integrated Biopharma and Pharma Solution (IBPS) marks its debut at the 3rd Annual Biosimilars APAC Summit on November 7-8, 2017 at The Hilton, Singapore. Honesty, Innovation and Transparency help you…
Regulatory requirement for Biosimilar Development – Purpose, Innovation and Cost
As the regulatory landscape is evolving for biosimilars, the intriguing challenges for the biosimilar development companies and manufacturers..
Can India be saved from the Breast Cancer epidemic staring at it???
October being the Breast Cancer awareness month, we thought that a discussion on breast cancer in India would be most appropriate to start the IBPS blog
2nd Annual Biosimilars Congress India 2017
The 2nd Annual Biosimilars Congress India 2017 took place on 08 - 09 August 2017 and was a successful event which attracted many Pharma Professionals under one roof.https://www.flickr.com/photos/130090256@N05/sets/72157687933436635 http://www.indiabiosimilars.com/Home.aspx
partners-news
IBPS joins hands with Auckland Clinical Studies (ACS), New Zealand to facilitate biosimilar/biologics/small molecule PK/PD and bioequivalence trials IBPS partners with TPG Biologics to facilitate high performance and low COGs…